Cabot (NYSE:CBT) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of Cabot (NYSE:CBT) from a buy rating to a hold rating in a research report sent to investors on Saturday,Wall Street Zen reports.

Several other analysts have also recently commented on the company. JPMorgan Chase & Co. lifted their price target on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. UBS Group cut their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Mizuho boosted their target price on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Finally, Truist Financial set a $100.00 price target on shares of Cabot in a research report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $87.80.

Cabot Trading Up 0.6%

Shares of CBT opened at $77.39 on Friday. Cabot has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The company has a market capitalization of $3.99 billion, a PE ratio of 21.80, a price-to-earnings-growth ratio of 9.06 and a beta of 0.83. The stock has a fifty day moving average of $82.59 and a two-hundred day moving average of $82.28. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts forecast that Cabot will post 6.35 EPS for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 28th were issued a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Friday, August 28th. Cabot’s dividend payout ratio (DPR) is 53.24%.

Insider Buying and Selling at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. The trade was a 25.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders sold 229,597 shares of company stock valued at $19,646,746. Insiders own 3.08% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. purchased a new stake in Cabot during the second quarter worth approximately $33,000. Caitong International Asset Management Co. Ltd raised its stake in shares of Cabot by 76.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 944 shares of the specialty chemicals company’s stock valued at $63,000 after acquiring an additional 410 shares during the period. Rockefeller Capital Management L.P. lifted its holdings in shares of Cabot by 115.3% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company’s stock valued at $76,000 after acquiring an additional 617 shares in the last quarter. Global Retirement Partners LLC acquired a new position in shares of Cabot during the 2nd quarter valued at $88,000. Finally, Parallel Advisors LLC boosted its position in Cabot by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock worth $139,000 after purchasing an additional 175 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot’s products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.